<?xml version="1.0" encoding="UTF-8"?><doi_batch version="4.3.7" xmlns="http://www.crossref.org/schema/4.3.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.crossref.org/schema/4.3.7 http://www.crossref.org/schema/deposit/crossref4.3.7.xsd">
		<head>
		<doi_batch_id>eamdacademy.org-AJfr-1789518387-n365737332</doi_batch_id>
		<timestamp>1789518387</timestamp>
		<depositor>
			<depositor_name>Eurasian Academy of Medicine and Dentistry</depositor_name>
			<email_address>info@eamdacademy.org</email_address>
		</depositor>
		<registrant>Eurasian Academy of Medicine and Dentistry</registrant>
	</head>
	<body>
		<journal>
			<journal_metadata>
				<full_title>Journal of Applied Pharmaceutical Technologies and Systems</full_title>
				<abbrev_title>J Appl Pharm Technol Syst</abbrev_title>
				<issn>3149-9589</issn>
			</journal_metadata>
			<journal_issue>
				<publication_date>
					<year>2024</year>
				</publication_date>
				<journal_volume>
					<volume>3</volume>
				</journal_volume>
				<issue>1</issue>
			</journal_issue>
			<journal_article publication_type="full_text">
				<titles>
					<title>Continuous Pharmaceutical Manufacturing Systems: Control Architectures, Process Robustness, and Regulatory Translation</title>
				</titles>
								<contributors>
          					<person_name sequence="first" contributor_role="author">
            <given_name>Hiroshi</given_name>
            <surname>Tanaka</surname>
					</person_name>
          					<person_name sequence="additional" contributor_role="author">
            <given_name>Yuki</given_name>
            <surname>Sato</surname>
					</person_name>
          					<person_name sequence="additional" contributor_role="author">
            <given_name>Kenji</given_name>
            <surname>Mori</surname>
					</person_name>
          					<person_name sequence="additional" contributor_role="author">
            <given_name>Rina</given_name>
            <surname>Okabe</surname>
					</person_name>
          					<person_name sequence="additional" contributor_role="author">
            <given_name>Takashi</given_name>
            <surname>Ito</surname>
					</person_name>
          				</contributors>
								<publication_date>
					<year>2024</year>
				</publication_date>
				<doi_data>
					<doi>10.68159/n365737332</doi>
					<resource>https://eamdacademy.org/pub/journal/3/article/n365737332</resource>
				</doi_data>
				<citation_list>
          					<citation key="rk-10.68159/n365737332-d326ca5b-62a2-4e4b-935c-31e42c9d5f24">
					  <unstructured_citation>Almaya A, De Belder L, Meyer R, Nagapudi K, Lin HRH, Leavesley I, et al. Control strategies for drug product continuous direct compression—state of control, product collection strategies, and startup/shutdown operations for the production of clinical trial materials and commercial products. J Pharm Sci. 2017;106(4):930-43.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-5c9be3a2-9119-4e0d-a341-6f5760eca7f0">
					  <unstructured_citation>Nasr MM, Krumme M, Matsuda Y, Trout BL, Badman C, Mascia S, et al. Regulatory perspectives on continuous pharmaceutical manufacturing: moving from theory to practice. J Pharm Sci. 2017;106(11):3199-206.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-e11c92cb-f60c-4a1f-8e99-2678be24da4f">
					  <unstructured_citation>Burcham CL, Florence AJ, Johnson MD. Continuous manufacturing in pharmaceutical process development and manufacturing. Annu Rev Chem Biomol Eng. 2018;9(1):253-81.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-f9dda672-47e1-45bd-a179-47d6ddc3d289">
					  <unstructured_citation>Domokos A, Nagy B, Szilágyi B, Marosi G, Nagy ZK. Integrated continuous pharmaceutical technologies—a review. Org Process Res Dev. 2021;25(4):721-39.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-37ba3ab2-35ab-4d20-8c17-3f73cae4577c">
					  <unstructured_citation>Kakhi M, Li J, Dorantes A. Regulatory experience with continuous manufacturing and real time release testing for dissolution in new drug applications. J Pharm Sci. 2023;112(10):2604-14.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-86ee8158-8eec-4de2-ac26-36e559ba9036">
					  <unstructured_citation>O&#039;Connor TF, Chatterjee S, Lam J, de la Ossa DH, Martinez-Peyrat L, Hoefnagel MH, et al. An examination of process models and model risk frameworks for pharmaceutical manufacturing. Int J Pharm X. 2024;8:100274.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-0f4dba65-50ca-4942-ada9-96d9f9dca018">
					  <unstructured_citation>Hyer A, Gregory D, Kay K, Le Q, Turnage J, Gupton F, et al. Continuous manufacturing of active pharmaceutical ingredients: current trends and perspectives. Adv Synth Catal. 2024;366(3):357-89.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-10e2b2d2-2987-4ba2-8815-d43572d3ad84">
					  <unstructured_citation>Vargas JM, Nielsen S, Cárdenas V, Gonzalez A, Aymat EY, Almodovar E, et al. Process analytical technology in continuous manufacturing of a commercial pharmaceutical product. Int J Pharm. 2018;538(1-2):167-78.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-15e45d1a-ee2e-47b6-8171-1960da2e94c4">
					  <unstructured_citation>Hurley S, Tantuccio A, Escotet-Espinoza MS, Flamm M, Metzger M. Development and use of a residence time distribution (RTD) model control strategy for a continuous manufacturing drug product pharmaceutical process. Pharmaceutics. 2022;14(2):355.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-be6999dd-93cb-41b9-8805-83f34bae5aba">
					  <unstructured_citation>Stauffer F, Vanhoorne V, Pilcer G, Chavez PF, Rome S, Schubert MA, et al. Raw material variability of an active pharmaceutical ingredient and its relevance for processability in secondary continuous pharmaceutical manufacturing. Eur J Pharm Biopharm. 2018;127:92-103.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-98f4d110-ad1f-4601-ae6b-b46a95626db4">
					  <unstructured_citation>Vanhoorne V, Vervaet C. Recent progress in continuous manufacturing of oral solid dosage forms. Int J Pharm. 2020;579:119194.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-b5fcd1e7-9e21-4c9d-aef6-6e7b61696ad9">
					  <unstructured_citation>Wahlich J. Continuous manufacturing of small molecule solid oral dosage forms. Pharmaceutics. 2021;13(8):1311.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-56e0e070-faac-4192-b5c6-22e35efbca21">
					  <unstructured_citation>Jung EA, Park YJ, Kim JE. Application of continuous manufacturing for solid oral dosage forms. J Pharm Investig. 2023;53(4):457-74.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-f7c87603-fb54-4da1-b158-0e11f21e2cc8">
					  <unstructured_citation>Mesbah A, Paulson JA, Lakerveld R, Braatz RD. Model predictive control of an integrated continuous pharmaceutical manufacturing pilot plant. Org Process Res Dev. 2017;21(6):844-54.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-b581775d-fc86-49b6-ab13-c519de5bc278">
					  <unstructured_citation>Bhaskar A, Barros FN, Singh R. Development and implementation of an advanced model predictive control system into continuous pharmaceutical tablet compaction process. Int J Pharm. 2017;534(1-2):159-78.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-bf4a174e-b556-4a12-b0a2-f7af6cbad1f1">
					  <unstructured_citation>Liu J, Su Q, Moreno M, Laird C, Nagy Z, Reklaitis G. Robust state estimation of feeding-blending systems in continuous pharmaceutical manufacturing. Chem Eng Res Des. 2018;134:140-53.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-e11554a6-3f7e-44f5-857e-1668a834f46c">
					  <unstructured_citation>Rehrl J, Karttunen AP, Nicolaï N, Hörmann T, Horn M, Korhonen O, et al. Control of three different continuous pharmaceutical manufacturing processes: Use of soft sensors. Int J Pharm. 2018;543(1-2):60-72.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-a9f32cbe-d305-45bb-a3e5-2667bd4f83a3">
					  <unstructured_citation>Su Q, Ganesh S, Moreno M, Bommireddy Y, Gonzalez M, Reklaitis GV, et al. A perspective on Quality-by-Control (QbC) in pharmaceutical continuous manufacturing. Comput Chem Eng. 2019;125:216-31.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-0c9a304f-3546-4a22-bb02-7c6f29c74281">
					  <unstructured_citation>Jelsch M, Roggo Y, Kleinebudde P, Krumme M. Model predictive control in pharmaceutical continuous manufacturing: A review from a user&#039;s perspective. Eur J Pharm Biopharm. 2021;159:137-42.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-20c71eed-a259-427d-8acd-d3fa729bef00">
					  <unstructured_citation>Jelsch M, Roggo Y, Brewer M, Geczi ZA, Heger P, Kleinebudde P, et al. Advanced process automation of a pharmaceutical continuous wet granulation line: Perspectives on the application of a model predictive control from solid feeders to dryer. Powder Technol. 2023;429:118936.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-2ec42f8f-310b-4e44-b135-5ffb67b94367">
					  <unstructured_citation>Su Q, Moreno M, Ganesh S, Reklaitis GV, Nagy ZK. Resilience and risk analysis of fault-tolerant process control design in continuous pharmaceutical manufacturing. J Loss Prev Process Ind. 2018;55:411-22.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-63ba9972-0f94-49cb-8e9c-6f5402b78c32">
					  <unstructured_citation>Tian G, Koolivand A, Arden NS, Lee S, O&#039;Connor TF. Quality risk assessment and mitigation of pharmaceutical continuous manufacturing using flowsheet modeling approach. Comput Chem Eng. 2019;129:106508.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-de9e26f6-5e11-4c61-91ac-ad92994d9d5c">
					  <unstructured_citation>Medendorp J, Shapally S, Vrieze D, Tolton K. Process control of drug product continuous manufacturing operations—a study in operational simplification and continuous improvement. J Pharm Innov. 2022;17(1):85-96.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-836ef115-dbd0-4212-b390-4f0af9fad7a4">
					  <unstructured_citation>Jelsch M, Roggo Y, Mohamad A, Kleinebudde P, Krumme M. Automatic system dynamics characterization of a pharmaceutical continuous production line. Eur J Pharm Biopharm. 2022;180:137-48.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-8afaa1b0-d7e7-49a1-81a4-28487dc9e5b8">
					  <unstructured_citation>Roggo Y, Jelsch M, Heger P, Ensslin S, Krumme M. Deep learning for continuous manufacturing of pharmaceutical solid dosage form. Eur J Pharm Biopharm. 2020;153:95-105.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-a4e8d123-46f8-4a71-9912-62a1477fe24a">
					  <unstructured_citation>Markl D, Warman M, Dumarey M, Bergman EL, Folestad S, Shi Z, et al. Review of real-time release testing of pharmaceutical tablets: State-of-the-art, challenges and future perspective. Int J Pharm. 2020;582:119353.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-1c80bd76-35f3-4ab0-967a-9cd257edb8d6">
					  <unstructured_citation>Kim EJ, Kim JH, Kim MS, Jeong SH, Choi DH. Process analytical technology tools for monitoring pharmaceutical unit operations: a control strategy for continuous process verification. Pharmaceutics. 2021;13(6):919.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-97b97ed6-bba0-4b62-a897-8207eb82a3e7">
					  <unstructured_citation>Su Q, Bommireddy Y, Shah Y, Ganesh S, Moreno M, Liu J, et al. Data reconciliation in the Quality-by-Design (QbD) implementation of pharmaceutical continuous tablet manufacturing. Int J Pharm. 2019;563:259-72.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/n365737332-e77f2857-7766-4198-819a-1e95e940af67">
					  <unstructured_citation>Huang YS, Sheriff MZ, Bachawala S, Gonzalez M, Nagy ZK, Reklaitis GV. Evaluation of a combined MHE-NMPC approach to handle plant-model mismatch in a rotary tablet press. Processes. 2021;9(9):1612.</unstructured_citation>
											</citation>
          				</citation_list>
			</journal_article>
		</journal>
	</body>
</doi_batch>
